Feedback / Questions
BHV-8000 - Biohaven
https://www.prnewswire.com/news-releases/biohaven-enrolls-first-patient-into-phase-23-trial-in-early-parkinsons-disease-targeting-neuroinflammation-with-novel-brain-penetrant-tyk2jak1-inhibitor-302467788.html
May 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next